Related Experiment Video
Updated: May 17, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
Pan-Cancer Analysis Identifies a Ras-Related GTPase as a Potential Modulator of Cancer
Hsiang-Yin Hsueh1,2,3, Kristyn Gumpper-Fedus1,2, Jelmer W Poelstra4
1Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Abstract:
Ras signaling regulates many cellular processes in cancer development. While well-known Ras-related oncogenes, such as KRAS, have been extensively explored, the role of other Ras-related genes in cancer remains poorly studied. Dexamethasone-induced Ras-related protein 1 (RASD1), a member of the Ras superfamily, is widely expressed across various tissues and is involved in inhibiting cell growth and inducing apoptosis, suggesting a potential role as a tumor suppressor. Here, we investigated RASD1 expression across multiple tissues and cancers, utilizing data from The Cancer Genome Atlas (TCGA), Human Protein Atlas, and Genotype-Tissue Expression (GTEx) databases. Our analysis revealed a significant downregulation of RASD1 mRNA expression in several cancer types compared to normal tissues, correlating with low levels of promoter methylation. Interestingly, high RASD1 expression correlated with a favorable prognosis in multiple cancers. Immune cell infiltration analysis indicated that elevated RASD1 expression is associated with an increased infiltration of CD4+ T cells and myeloid-derived dendritic cells in cancer. Furthermore, the expression of genes exhibiting similar expression patterns as RASD1 suggest that RASD1 may play a role in interleukin-4-mediated apoptosis and could regulate the transcription of the phosphatase and tensin homolog (PTEN) gene. Overall, these findings suggest that RASD1 may modulate immune signaling and tumor suppressive pathways.
Insights
Dexamethasone-induced Ras-related protein 1 (RASD1) is downregulated in many cancers, suggesting a tumor suppressor role. High RASD1 expression correlates with better prognosis and increased immune cell infiltration, indicating its potential in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Ras signaling is crucial in cancer, but roles of less-studied Ras-related genes are unclear.
- Dexamethasone-induced Ras-related protein 1 (RASD1) exhibits tumor-suppressive functions (inhibits growth, induces apoptosis).
Purpose of the Study:
- To investigate RASD1 expression patterns across various human tissues and cancers.
- To explore the correlation between RASD1 expression, cancer prognosis, and immune cell infiltration.
Main Methods:
- Analysis of RASD1 mRNA expression using The Cancer Genome Atlas (TCGA), Human Protein Atlas, and Genotype-Tissue Expression (GTEx) databases.
- Correlation analysis with promoter methylation, patient prognosis, and immune cell infiltration.
- Exploration of co-expressed genes to infer functional pathways.
Main Results:
- RASD1 mRNA expression is significantly downregulated in multiple cancer types compared to normal tissues.
- Downregulation correlates with low promoter methylation; high RASD1 expression is linked to favorable prognosis.
- Elevated RASD1 expression is associated with increased infiltration of CD4+ T cells and myeloid-derived dendritic cells.
Conclusions:
- RASD1 functions as a potential tumor suppressor gene with downregulated expression in various cancers.
- RASD1 expression may serve as a prognostic biomarker and influence anti-tumor immunity.
- RASD1 potentially modulates immune signaling, interleukin-4-mediated apoptosis, and PTEN gene transcription.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GTPases and their Regulation
Large G-proteins,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation